Skip to main content
Top
Published in: CEN Case Reports 1/2014

01-05-2014 | Case Report

Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow

Authors: Keiichi Kaneko, Koichi Seta, Jun Soma, Takashi Kuwahara, Mitsuteru Koizumi, Yuko Kikuchi, Akira Sugawara, Kensei Yahata

Published in: CEN Case Reports | Issue 1/2014

Login to get access

Abstract

A 32-year-old Japanese woman presented with hypertension, nephrotic syndrome, microhematuria, and severe hypocomplementemia. Her serum creatinine concentration increased from 1.46 mg/dL (129.0 μmol/L) to 3.46 mg/dL (305.8 μmol/L) over 1 month. Renal biopsy revealed Congo red-negative nodular glomerulosclerosis accompanied by mesangial proliferation. There was extensive staining of immunoglobulin (Ig) G in the glomerular and tubular basement membranes and expanded mesangial regions. Staining was negative for IgA, IgM, and kappa and lambda light chains and positive for the gamma 1 IgG subclass. Staining for constant domains of the gamma heavy chains showed a deletion of the first constant domain (CH1). Electron microscopy revealed electron-dense deposits in the glomerular and tubular basement membranes and mesangium. These findings indicated gamma 1-heavy chain deposition disease (HCDD). Serum and urine immunoelectrophoresis revealed an IgG kappa monoclonal band, whereas bone marrow biopsy revealed monoclonal plasmacytosis with positive staining for kappa chains. HCDD associated with kappa light chain is extremely rare. We report the first case of HCDD with IgG kappa detected in the serum, urine, and bone marrow.
Literature
1.
go back to reference Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogne M, Chauffert B, et al. Brief report: heavy-chain deposition disease. N Engl J Med. 1993;329(19):1389–93.PubMedCrossRef Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogne M, Chauffert B, et al. Brief report: heavy-chain deposition disease. N Engl J Med. 1993;329(19):1389–93.PubMedCrossRef
2.
go back to reference Moulin B, Deret S, Mariette X, Kourilsky O, Imai H, Dupouet L, et al. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J Am Soc Nephrol. 1999;10(3):519–28.PubMed Moulin B, Deret S, Mariette X, Kourilsky O, Imai H, Dupouet L, et al. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J Am Soc Nephrol. 1999;10(3):519–28.PubMed
3.
go back to reference Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12(7):1482–92.PubMed Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12(7):1482–92.PubMed
4.
go back to reference Tubbs RR, Berkley V, Valenzuela R, McMahon JT, Gephardt GN, Fishleder AJ, et al. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease. Mod Pathol. 1992;5(2):185–90.PubMed Tubbs RR, Berkley V, Valenzuela R, McMahon JT, Gephardt GN, Fishleder AJ, et al. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease. Mod Pathol. 1992;5(2):185–90.PubMed
5.
go back to reference Katz A, Zent R, Bargman JM. IgG heavy-chain deposition disease. Mod Pathol. 1994;7(8):874–8.PubMed Katz A, Zent R, Bargman JM. IgG heavy-chain deposition disease. Mod Pathol. 1994;7(8):874–8.PubMed
6.
go back to reference Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol. 1995;44(6):394–9.PubMed Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol. 1995;44(6):394–9.PubMed
7.
go back to reference Rott T, Vizjak A, Lindic J, Hvala A, Perkovic T, Cernelc P. IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant. 1998;13(7):1825–8.PubMedCrossRef Rott T, Vizjak A, Lindic J, Hvala A, Perkovic T, Cernelc P. IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant. 1998;13(7):1825–8.PubMedCrossRef
8.
go back to reference Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D’Agati VD. Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis. 1999;33(5):954–62.PubMedCrossRef Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D’Agati VD. Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis. 1999;33(5):954–62.PubMedCrossRef
9.
go back to reference Ronco P, Plaisier E, Mougenot B, Aucouturier P. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol. 2006;1(6):1342–50.PubMedCrossRef Ronco P, Plaisier E, Mougenot B, Aucouturier P. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol. 2006;1(6):1342–50.PubMedCrossRef
10.
go back to reference Herzenberg AM, Kiaii M, Magil AB. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype. Am J Kidney Dis. 2000;35(5):E25.PubMedCrossRef Herzenberg AM, Kiaii M, Magil AB. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype. Am J Kidney Dis. 2000;35(5):E25.PubMedCrossRef
11.
go back to reference Herzenberg AM, Lien J, Magil AB. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case. Am J Kidney Dis. 1996;28(1):128–31.PubMedCrossRef Herzenberg AM, Lien J, Magil AB. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case. Am J Kidney Dis. 1996;28(1):128–31.PubMedCrossRef
12.
go back to reference Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J. A case of gamma 1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med. 2010;49(14):1411–5.PubMedCrossRef Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J. A case of gamma 1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med. 2010;49(14):1411–5.PubMedCrossRef
13.
go back to reference Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, et al. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis. 2004;43(1):E10–6.PubMedCrossRef Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, et al. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis. 2004;43(1):E10–6.PubMedCrossRef
14.
go back to reference Husby G, Blichfeldt P, Brinch L, Brandtzaeg P, Mellbye OJ, Sletten K, et al. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? Scand J Rheumatol. 1998;27(4):257–64.PubMed Husby G, Blichfeldt P, Brinch L, Brandtzaeg P, Mellbye OJ, Sletten K, et al. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? Scand J Rheumatol. 1998;27(4):257–64.PubMed
15.
go back to reference Vedder AC, Weening JJ, Krediet RT. Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. Nephrol Dial Transplant. 2004;19(5):1302–4.PubMedCrossRef Vedder AC, Weening JJ, Krediet RT. Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. Nephrol Dial Transplant. 2004;19(5):1302–4.PubMedCrossRef
16.
go back to reference Corcos D, Osborn MJ, Matheson LS. B-cell receptors and heavy chain diseases: guilty by association? Blood. 2011;117(26):6991–8.PubMedCrossRef Corcos D, Osborn MJ, Matheson LS. B-cell receptors and heavy chain diseases: guilty by association? Blood. 2011;117(26):6991–8.PubMedCrossRef
17.
go back to reference Roussel A, Spinelli S, Deret S, Navaza J, Aucouturier P, Cambillau C. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem. 1999;260(1):192–9.PubMedCrossRef Roussel A, Spinelli S, Deret S, Navaza J, Aucouturier P, Cambillau C. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem. 1999;260(1):192–9.PubMedCrossRef
18.
go back to reference Ronco PM, Alyanakian MA, Mougenot B, Aucouturier P. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol. 2001;12(7):1558–65.PubMed Ronco PM, Alyanakian MA, Mougenot B, Aucouturier P. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol. 2001;12(7):1558–65.PubMed
19.
go back to reference Soma J, Tsuchiya Y, Sakuma T, Sato H. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease. Clin Nephrol. 2008;69(5):383–6.PubMedCrossRef Soma J, Tsuchiya Y, Sakuma T, Sato H. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease. Clin Nephrol. 2008;69(5):383–6.PubMedCrossRef
20.
go back to reference Tan S, Pon K, Bargman J, Ghazarian D. Generalized cutis laxa associated with heavy chain deposition disease. J Cutan Med Surg. 2003;7(5):390–4.PubMedCrossRef Tan S, Pon K, Bargman J, Ghazarian D. Generalized cutis laxa associated with heavy chain deposition disease. J Cutan Med Surg. 2003;7(5):390–4.PubMedCrossRef
21.
go back to reference Komatsuda A, Maki N, Wakui H, Ohtani H, Hatakeyama T, Yasuda T, et al. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up. Nephrol Dial Transplant. 2005;20(2):434–7.PubMedCrossRef Komatsuda A, Maki N, Wakui H, Ohtani H, Hatakeyama T, Yasuda T, et al. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up. Nephrol Dial Transplant. 2005;20(2):434–7.PubMedCrossRef
22.
go back to reference Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadjikonstantinou V, Dimopoulos MA. Treatment of light chain deposition disease with bortezomib and dexamethasone. Haematologica. 2009;94(2):300–2.PubMedCentralPubMedCrossRef Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadjikonstantinou V, Dimopoulos MA. Treatment of light chain deposition disease with bortezomib and dexamethasone. Haematologica. 2009;94(2):300–2.PubMedCentralPubMedCrossRef
Metadata
Title
Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow
Authors
Keiichi Kaneko
Koichi Seta
Jun Soma
Takashi Kuwahara
Mitsuteru Koizumi
Yuko Kikuchi
Akira Sugawara
Kensei Yahata
Publication date
01-05-2014
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2014
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-013-0083-0

Other articles of this Issue 1/2014

CEN Case Reports 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.